The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Ciltacabtagene autoleucel in patients with lenalidomide-refractory multiple myeloma: CARTITUDE-2 cohort A expansion subgroup.
 
Adam D. Cohen
Consulting or Advisory Role - Abbvie; Arcellx; Bristol Meyers Squibb; GlaxoSmithKline; Ichnos Sciences; ITeos Therapeutics; Janssen Oncology; Novartis; Pfizer; Roche/Genentech; Takeda
Research Funding - Genentech/Roche (Inst); GlaxoSmithKline (Inst); Janssen Oncology (Inst); Novartis (Inst)
Patents, Royalties, Other Intellectual Property - Patents related to CAR T cells and biomarkers of Cytokine Release Syndrome
Travel, Accommodations, Expenses - Abbvie; Bristol-Myers Squibb; Ichnos Sciences; Janssen Oncology; Janssen Oncology
 
Peter M. Voorhees
Consulting or Advisory Role - Abbvie; AstraZeneca; Bristol-Myers Squibb; Janssen; Lava Therapeutics; Regeneron; Sanofi
Research Funding - Janssen; Regeneron
Travel, Accommodations, Expenses - Janssen; Sanofi
 
Thomas G. Martin
Consulting or Advisory Role - GlaxoSmithKline; Legend Biotech; Pfizer
Research Funding - AMGEN (Inst); BMSi; Janssen Oncology (Inst); Sanofi (Inst)
 
Alexander M. Lesokhin
Honoraria - ITeos Therapeutics; Janssen; Legend Biotech; Pfizer; Sanofi; SVB Leerink; SVB Leerink; Trillium Therapeutics
Consulting or Advisory Role - Arcellx; Pfizer; Trillium Therapeutics
Research Funding - Bristol-Myers Squibb (Inst); Genentech (Inst); Janssen Oncology (Inst); Pfizer (Inst); Sanofi (Inst); Trillium Therapeutics (Inst)
Patents, Royalties, Other Intellectual Property - Serametrix, Inc
 
Jens Hillengass
Employment - Roswell Park Cancer Institute
Honoraria - Amgen; BeiGene; Beijing Medical Award Foundation; Curio Science; Janssen Biotech
Consulting or Advisory Role - Axxess Networks; Bristol-Myers Squibb/Celgene; GlaxoSmithKline; Intellisphere; Janssen Biotech; Sanofi
Research Funding - Celgene (Inst)
 
Jonathan L. Kaufman
Consulting or Advisory Role - Abbvie; Bristol-Myers Squibb/Celgene; Incyte; Sanofi; Sebia
Research Funding - Abbvie/Genentech (Inst); Amgen (Inst); BMS (Inst); BMS (Inst); Celgene (Inst); GlaxoSmithKline (Inst); Heidelberg Pharma (Inst); Janssen (Inst); Novartis (Inst); Sutro Biopharma (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - BMS; Sanofi
 
Jordan Mark Schecter
Employment - Janssen Oncology
Stock and Other Ownership Interests - Janssen Oncology
 
Kevin C. De Braganca
Employment - Johnson & Johnson/Janssen
Stock and Other Ownership Interests - Johnson & Johnson/Janssen
Patents, Royalties, Other Intellectual Property - Johnson & Johnson/Janssen
 
Helen Varsos
Employment - Johnson & Johnson/Janssen
Stock and Other Ownership Interests - Johnson & Johnson/Janssen
 
Christina Corsale
Employment - Janssen
 
Pankaj Mistry
Employment - Janssen; JJ Innovative Medicine
Stock and Other Ownership Interests - Janssen; JJ Innovative Medicine
 
Qingxuan Song
Employment - Janssen
 
Mythili Koneru
Employment - Legend Biotech
Leadership - Legend Biotech
Stock and Other Ownership Interests - Legend Biotech
 
Muhammad Akram
Employment - Legend Biotech
 
Octavio Costa Filho
Employment - Legend Biotech
Stock and Other Ownership Interests - Legend Biotech
 
Hermann Einsele
Honoraria - Amgen; Bristol-Myers Squibb; Celgene; GlaxoSmithKline; Janssen; Novartis; Sanofi; Takeda
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Celgene; GlaxoSmithKline; Janssen; Novartis; Roche; Sanofi; Takeda
Research Funding - Amgen (Inst); Bristol-Myers Squibb; Celgene (Inst); GlaxoSmithKline; Janssen (Inst); Novartis; Sanofi
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; Celgene; Janssen